Clinical Trial Update: Cartilage Biomarkers and HEAD-US Score in Severe Hemophilia A Patients Receiving FVIII Prophylaxis [NA]

View source ↗

Summary

An update on cartilage biomarkers and HEAD-US ultrasound scores in patients with severe Hemophilia A receiving Factor VIII prophylaxis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Factor VIII prophylaxis (Factor VIII)

Snippet

Sponsor: Chulalongkorn University | Conditions: Hemophilia A | NA | Status: ENROLLING_BY_INVITATION